Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

COAG

Hemab Therapeutics Holdings Inc

May 29 • 04:00PM ET

28.50

+0.50 1.79 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: LABT VBIO ABVE ABVC ACET AARD AAPG ABEO ABOS ABCL

| Held by: TMSL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	30.43%	Shs Outstand	46.71M	Perf Week	8.37%
Market Cap	1.33B	Forward P/E	-	EPS next Y	-2.38	Insider Trans	25.67%	Shs Float	32.49M	Perf Month	-
Enterprise Value	1.53B	PEG	-	EPS next Q	-	Inst Own	32.75%	Short Float	2.34%	Perf Quarter	-
Income	-	P/S	-	EPS this Y	96.04%	Inst Trans	-72.88%	Short Ratio	1.73	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	11.30%	ROA	-	Short Interest	0.76M	Perf YTD	-16.18%
Book/sh	-4.25	P/C	8.14	EPS next 5Y	64.71%	ROE	-	52W High	36.61 -22.15%	Perf Year	-
Cash/sh	3.50	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	23.00 23.91%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.32% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	2.91	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	12.85	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.35	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	12.85	EPS Q/Q	-	SMA20	5.50%	Beta	-	Target Price	41.75
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	5.50%	Rel Volume	0.28	Prev Close	28.00
Employees	72	LT Debt/Eq	-	Earnings	-	SMA200	5.50%	Avg Volume	438.29K	Price	28.50
IPO	May 01, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	123,057	Change	1.79%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)